Clinical Data AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data BioSpaceModerna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer.Clinical DataRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) BioSpace Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer. Clinical DataRead full story Post navigation Previous: MSD, Eisai report setback in first-line kidney cancer trialNext: Novo Nordisk preps filings for sickle cell drug etavopivat Related Stories Clinical Data Novartis hit as Lp(a) drug fails cardio outcomes trial pharminent September 7, 2026 Clinical Data Major trial of Roche Alzheimer’s drug kicks off in Europe pharminent September 7, 2026 Clinical Data AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study pharminent September 4, 2026